Login / Signup

A Single-center Experience in Treating Young Children at High Risk For Severe COVID-19 With Sotrovimab.

Giulia PruccoliNicoletta BertorelloElisa FunicielloFederica MignoneErika SilvestroCarlo ScolfaroSilvia Garazzino
Published in: The Pediatric infectious disease journal (2022)
Keyphrases
  • coronavirus disease
  • sars cov
  • early onset
  • respiratory syndrome coronavirus
  • drug induced